Green Cross Holdings Corporation
KRX:005250.KS
Overview | Financials
Company Name | Green Cross Holdings Corporation |
Symbol | 005250.KS |
Currency | KRW |
Price | 16,220 |
Market Cap | 728,832,399,600 |
Dividend Yield | 1.95% |
52-week-range | 12,940 - 18,490 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Il-Sup Huh Ph.D. |
Website | https://www.greencross.com |
An error occurred while fetching data.
About Green Cross Holdings Corporation
Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu. It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD